Check out our new research on developing a model for tumor infiltrating lymphocyte (TIL) therapy for cholangiocarcinoma (CCA) by the Lesinski and Paulos Labs! @lesinskilab.bsky.social @chrystalpaulos.bsky.social academic.oup.com/jimmunol/adv...

The City of Atlanta is opening its first municipal grocery store today. The city is spending $3.5 million in partnership with a neighborhood grocery chain in an effort to eliminate a downtown food desert. www.wsbtv.com/news/local/a...

www.v.org/grants/chrys... Honored to be awarded the All-Star V Foundation grant! Inspired by great team efforts between #Paulos and #Lesinski labs! Props to cell therapy gurus @megen-w.bsky.social #AnnaCole @meganmw.bsky.social and crew @winshipcancer.emory.edu

🧵1/ New in @Cancer_Cell: Our lab discovered that Th17 cells must team up with B cells to eliminate tumors, and prevent it from coming back. 🔗 Read: www.cell.com/cancer-cell/... 🧬This unexpected immune duo sparks tumor immunity. 🖼️Image: See schematic Th17/B cell antitumor action!

Check out our new paper in Hepatology on how myeloid cells limit immunotherapy in preclinical cholangiocarcinoma models! Disease site matters! @chrystalpaulos.bsky.social @megen-w.bsky.social @winshipcancer.emory.edu many others! pubmed.ncbi.nlm.nih.gov/40590857/

Amazing talk by Dr. Ayana Ruffin @winship on the importance of CD2 in adoptive immunotherapy of cancer. It’s a T:B thing. #2025SIS on the UVA campus.

Not a trend I will partake in. :/

This week I will be attending the @helloeacr.bsky.social conference, entitled "Defense is the Best Attack," where we'll catch up on the latest advances in immuno-oncology and advanced therapies. It's always a great opportunity to meet people and learn from the best. Hoping to meet you all there! 😁🧪

Excited to present at the first Breast Center Translational Research Seminar Series @winshipcancer.emory.edu Thank Dr. Shipra Gandhi for the invite.

What is the most important unanswered questions to address in the field of cancer immunotherapy?

Delighted to present our labs exciting work on T cell metabolism and cancer immunotherapy today at AACR by Guillermo Rangel Rivera and Soundharya Kumaresan!

Our findings highlight the critical role of T cell trafficking to the lymph nodes in shaping neoantigen-specific antitumor responses and offers insight for improving adoptive cellular therapies www.biorxiv.org/content/10.1...

Check out this awesome body of elegant work by @lesinskilab.bsky.social @winshipatemory.bsky.social on the immune landscape of primary vs metastatic tumor of patients with pancreatic cancer. Must read!!!!

Stellar team!!

Inspiring (as always) @cholangiocarcinoma.bsky.social annual meeting comes to a close. Our @winshipatemory.bsky.social team returns motivated by survivors, patients and caregivers to make a difference! @megen-w.bsky.social @chrystalpaulos.bsky.social

Excited to present our labs work on novel T cell therapies @clevelandclinic.bsky.social virtually @winshipatemory.bsky.social Thank you for the invite #LilyWang!

💥Cheers to Megen Wittling @megen-w.bsky.social @winshipatemory.bsky.social for presenting exciting work on the distinct trafficking & activation patterns of adoptively transferred CD8 T cells that recognize non-mutated va mutated tumors.

Going to talk about antitumorT cell prowess at KUMC today. Thanks to Dr. Kalyani Pyaram for inviting me to visit and talk about our labs work @winshipatemory.bsky.social

A study in Nature Immunology finds that a single injection of CAR T cells, designed to target drivers of allergic reactions, represses the signs and symptoms of allergic asthma in mice for at least a year. go.nature.com/3VeWuVg 🧪

#CUAnschutz researchers have developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against #cancer cells that are harder for prior CAR-T therapies to detect and fight. 🗞️⬇️

From 2010 to 2016 (latest data I have ), NIH research contributed to EVERY drug approved by the FDA

Delighted to present at the MD Anderson annual retreat this year in Galveston Texas.

We survived the Spartan Trial Run!

3 points of progress vs pancreatic cancer! 1. Neoantigen vaccines www.nature.com/articles/s41... 2. KRAS drugs www.wsj.com/health/healt... 3. Early diagnosis www.science.org/doi/10.1126/...

The Spring Scientific is almost here and will take place on March 12–14, 2025. #SITC will bring the brightest minds and next generation of leaders together to explore promising #science and develop novel opportunities to address these challenges. Register: go.sitcancer.org/4fupoc0

Very well done article on pancreatic cancer @wsj.com highlighting hope in a devastating disease. Adding the note that fundamental discoveries related to Kras were derived from NIH funding supported by tax dollars well spent.

NOW AVAILABLE: SITC Fellowships totaling $300,000 in funding! SITC is calling early career investigators looking for potential funding opportunities to apply with a Letter of Intent. Learn more about the application process here: sitcancer.org/fellowships #SITCFellowship #IO #grant #funding

Congrats to our talented grad student Megen Wittling for being award this NCI F30 grant for her work in adoptive immunotherapy today! @megen-w.bsky.social @winshipatemory.bsky.social @sitcancer.bsky.social #EmoryMSTP

Excellent talk by Dr. Zach Buchwald @zach-buchwald.bsky.social from @winshipatemory.bsky.social on immunotherapy in special patient populations. Talks about his amazing work on brain meta and circadian rhythm in immunity!! #CIWS2025 @sitcancer.bsky.social

Great talk by Dr. Gregory Lesinski @lesinskilab.bsky.social @winshipatemory.bsky.social on how to get predictive biomarkers in every clinical trial @sitcancer.bsky.social #CIWS2025

💥 Dr. Greg Lesinski @lesinskilab.bsky.social @sitcancer.bsky.social gives an outstanding talk on harnessing combination immunotherapies in preclinical models to guide new clinical trials for patients. #CIWS2025 @sitcancer.bsky.social 💥

Dr. Yina Huang brings the house down with her AMAZING talk on harnessing synthetic biology to augment next generation cell therapy for cancer patients at Winter School @sitcancer.bsky.social 💥

B cell guru and talented cancer immunotherapist Dr. Tullia Bruno at UPitt delivers an inspiring talk at Winter School today in Austin! 💥 @sitcancer.bsky.social

There is more to do. There is more people to help with cancer research and immunotherapy clinical trials.

Dr. Sumit Subudhi talks about a patient who picked this new therapy called anti-CTLA4 therapy over going to hospice. He was cured of melanoma! @sitcancer.bsky.social m #CIWS2025 Winter school. Cancer research advances medicine and gives more days to life!!!

Excellent talk by trailblazer Dr. Dan Powell @pennmedicine.bsky.social on adoptive immunotherapy and CAR T cells!@l @sitcancer.bsky.social #CIWS2025 Winter school in Austin.

Wonder virtual talk by the one and only Dr Greg Delgoffe @delgoffelab.bsky.social on the immunosuppression in the tumor we must understand and battle to make a difference in our patients! #CIWS2026 @sitcancer.bsky.social

Great talks by Drs. Kristin Anderson @immunegirl.bsky.social and Vic Engelhard from UVA at #CIWS2025 in Austin Tx @sitcancer.bsky.social on adaptive immunity and the tumor microenvironment.

The fab Dr. Yana Najjar kicks off cancer immunotherapy winter school #CIWS2025 to talk about the history of the field! Elegant and wonderful speaker. @upittpress.bsky.social

Honored to co-lead the cancer immunology research program @winship with Dr. Rafi Ahmed and so many stellar and passionate translational scientists at Emory.

Inspiring talk by Dr. Gregory Lesinski @lesinskilab.bsky.social on the wins and challenges of augmenting immunotherapy against cholangiocarcinoma @winshipatemory.bsky.social @sitcancer.bsky.social @cholangiocarcinoma.bsky.social

Cheers to @megen-w.bsky.social and #HeatherLin in the CB program @winshipatemory.bsky.social for brilliant talks on adoptive immunotherapy in yesterdays seminar series.

Excited for the bright and creative Dr. Lesinski @lesinskilab.bsky.social to present his teams elegant work @winshipatemory.bsky.social today!! @sitcancer.bsky.social #1 innovator!